Breast Lesion Localization Methods Market in New Advancements in Screening by Top Key Players Cook Medical Inc., Argon Medical Devices, Inc, C. R. Bard, Inc., SOMATEX Medical Technologies GmbH, Tsunami S.r.l, Sterylab Medical and Biopsybell Srl

Rapid strides made in technology and keen interest of healthcare providers to integrate cutting-edge solutions backed up by supportive government norms is fueling growth of this highly lucrative market, especially in developed regions. Furthermore, rise in prevalence of breast cancer globally, especially in Asia Pacific countries would inadvertently support market growth in the near future.

In order to alleviate this spike in incidence rate of the malady, governments are focusing on strengthening the healthcare infrastructure through supportive regulatory norms and investments. Government and non-government organizations are actively focusing on developing awareness programs regarding breast cancer. Such initiatives are projected to bring about a rapid shift in market dynamics, with Asia Pacific taking on the mantle from North America to emerge as the largest market for breast lesion localization methods.

Free Request Sample Copy of This Report: https://www.coherentmarketinsights.com/insight/request-sample/104

According to The Economist Intelligence Unit Limited, in 2016, China had a comparatively low breast cancer burden by world standards, with 2012 age standardized ratio for incidence and mortality around 22.1 and 5.4 per 100,000 respectively. However, in India breast cancer incidence by global standards in 2012 age standardized ratio was around 25.8 per 100,000. Despite what the statistics tend to suggest, the extent of the disease has surged significantly unlike the steady rise as estimated earlier in 2009.

Various manufacturers are developing new products to strengthen their foothold in the market, which in turn, is expected to favor growth of the breast lesion localization methods market. For instance, according to Xconomy, Inc., in 2017, Elucent Medical, a newly formed organization, raised around US$ 7.0 million for development of breast cancer medical devices to enrich its product portfolio. Furthermore, growing healthcare expenditure by local governments is contributing to growth in healthcare infrastructure, primarily in emerging economies.

Get PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/104

Key players in the market are focusing on upgrading existing devices and inorganic growth strategies such as mergers and acquisitions. For instance, in 2016, AbbVie – a global biopharmaceutical company – acquired Stemcentrx, which has four novel compounds under clinical trials for solid tumor indications that further includes triple negative breast cancer, ovarian cancer, and non-small cell lung cancer.

Company Profiles
Cook Medical Inc. *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans
Argon Medical Devices, Inc.
C. R. Bard, Inc.
SOMATEX Medical Technologies GmbH
Tsunami S.r.l
Sterylab Medical
Biopsybell Srl.

Purchase Copy of This Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/104

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Us:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.